134 related articles for article (PubMed ID: 25056232)
1. Hydroxysafflor yellow a attenuates small airway remodeling in a rat model of chronic obstructive pulmonary disease.
Wang Y; Xue C; Dong F; Peng Y; Zhang Y; Jin M; Zang B; Tan L
Biol Pharm Bull; 2014; 37(10):1591-8. PubMed ID: 25056232
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats.
Jin M; Wang L; Wu Y; Zang BX; Tan L
Chin J Integr Med; 2018 Jan; 24(1):32-39. PubMed ID: 29294256
[TBL] [Abstract][Full Text] [Related]
3. Protective Effect of Hydroxysafflor Yellow A on Inflammatory Injury in Chronic Obstructive Pulmonary Disease Rats.
Jin M; Xue CJ; Wang Y; Dong F; Peng YY; Zhang YD; Zang BX; Tan L
Chin J Integr Med; 2019 Oct; 25(10):750-756. PubMed ID: 30588579
[TBL] [Abstract][Full Text] [Related]
4. Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice.
Jin M; Wu Y; Wang L; Zang B; Tan L
Phytother Res; 2016 Apr; 30(4):577-87. PubMed ID: 26777519
[TBL] [Abstract][Full Text] [Related]
5. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
Pan R; Zhang Y; Zang B; Tan L; Jin M
J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091
[TBL] [Abstract][Full Text] [Related]
6. Hydroxysafflor Yellow A Alleviates Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Mice.
Zhang Y; Song L; Pan R; Gao J; Zang BX; Jin M
Biol Pharm Bull; 2017; 40(2):135-144. PubMed ID: 28154251
[TBL] [Abstract][Full Text] [Related]
7. Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats.
Li L; Dong P; Hou C; Cao F; Sun S; He F; Song Y; Li S; Bai Y; Zhu D
J Ethnopharmacol; 2016 Jun; 186():224-233. PubMed ID: 27063983
[TBL] [Abstract][Full Text] [Related]
8. Hydroxysafflor yellow A alleviates early inflammatory response of bleomycin-induced mice lung injury.
Wu Y; Wang L; Jin M; Zang BX
Biol Pharm Bull; 2012; 35(4):515-22. PubMed ID: 22466555
[TBL] [Abstract][Full Text] [Related]
9. Hydroxysafflor yellow A attenuate lipopolysaccharide-induced endothelium inflammatory injury.
Jin M; Sun CY; Zang BX
Chin J Integr Med; 2016 Jan; 22(1):36-41. PubMed ID: 26015073
[TBL] [Abstract][Full Text] [Related]
10. The ability of hydroxysafflor yellow a to attenuate lipopolysaccharide-induced pulmonary inflammatory injury in mice.
Sun CY; Pei CQ; Zang BX; Wang L; Jin M
Phytother Res; 2010 Dec; 24(12):1788-95. PubMed ID: 20564507
[TBL] [Abstract][Full Text] [Related]
11. Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis.
Zhang Y; Guo J; Dong H; Zhao X; Zhou L; Li X; Liu J; Niu Y
Eur J Pharmacol; 2011 Jun; 660(2-3):438-44. PubMed ID: 21536026
[TBL] [Abstract][Full Text] [Related]
12. Hydroxysafflor yellow A ameliorates lipopolysaccharide-induced acute lung injury in mice via modulating toll-like receptor 4 signaling pathways.
Liu YL; Liu YJ; Liu Y; Li XS; Liu SH; Pan YG; Zhang J; Liu Q; Hao YY
Int Immunopharmacol; 2014 Dec; 23(2):649-57. PubMed ID: 25466274
[TBL] [Abstract][Full Text] [Related]
13. Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.
Hu N; Duan J; Li H; Wang Y; Wang F; Chu J; Sun J; Liu M; Wang C; Lu C; Wen A
PLoS One; 2016; 11(4):e0153409. PubMed ID: 27088510
[TBL] [Abstract][Full Text] [Related]
14. Hydroxysafflor yellow A attenuates carbon tetrachloride-induced hepatic fibrosis in rats by inhibiting ERK5 signaling.
Zhang YB; Dong HY; Zhao XM; Fan L; Zou Y; Zhang C; Li G; Liu JC; Niu YC
Am J Chin Med; 2012; 40(3):481-94. PubMed ID: 22745065
[TBL] [Abstract][Full Text] [Related]
15. Hydroxysafflor yellow A suppresses angiogenesis of hepatocellular carcinoma through inhibition of p38 MAPK phosphorylation.
Zhang J; Li J; Song H; Xiong Y; Liu D; Bai X
Biomed Pharmacother; 2019 Jan; 109():806-814. PubMed ID: 30551534
[TBL] [Abstract][Full Text] [Related]
16. Hydroxysafflor yellow A of Carthamus tinctorius attenuates lung injury of aged rats exposed to gasoline engine exhaust by down-regulating platelet activation.
Wang C; Wang C; Ma C; Huang Q; Sun H; Zhang X; Bai X
Phytomedicine; 2014 Feb; 21(3):199-206. PubMed ID: 24192212
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies.
Zhu H; Wang Z; Ma C; Tian J; Fu F; Li C; Guo D; Roeder E; Liu K
Planta Med; 2003 May; 69(5):429-33. PubMed ID: 12802724
[TBL] [Abstract][Full Text] [Related]
18. Hydroxysafflor yellow A attenuates the expression of inflammatory cytokines in acute soft tissue injury.
Dong F; Xue C; Wang Y; Peng Y; Zhang Y; Jin M; Zang B
Sci Rep; 2017 Jan; 7():40584. PubMed ID: 28074914
[TBL] [Abstract][Full Text] [Related]
19. Hydroxysafflor yellow A suppresses liver fibrosis induced by carbon tetrachloride with high-fat diet by regulating PPAR-γ/p38 MAPK signaling.
Liu Q; Wang CY; Liu Z; Ma XS; He YH; Chen SS; Bai XY
Pharm Biol; 2014 Sep; 52(9):1085-93. PubMed ID: 24618007
[TBL] [Abstract][Full Text] [Related]
20. Topical application of Hydroxysafflor Yellow A accelerates the wound healing in streptozotocin induced T1DM rats.
Gao SQ; Chang C; Niu XQ; Li LJ; Zhang Y; Gao JQ
Eur J Pharmacol; 2018 Mar; 823():72-78. PubMed ID: 29408092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]